Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Loperamide Hydrochloride,Simethicone
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Limited Received ANDA Approval for Loperamide HCl and Simethicone Tablets
Details : Generic of Loperamide Hydrochloride and Simethicone Tablets have been approved which is indicated to relieve symptoms of diarrhea plus bloating, pressure and cramps, commonly referred to as gas.
Product Name : Imodium Multi-Symptom Relief-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 30, 2022
Lead Product(s) : Loperamide Hydrochloride,Simethicone
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Wonderbelly Expands Digestive Health Medicines with Launch of Bloat + Gas Relief Product
Details : Bloat + Gas Relief (simethicone) is a USFDA approved antifoaming agent which is indicated for the treatment of bloating, gas discomfort, abdominal pressure, and associated fullness.
Product Name : Bloat + Gas Relief
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 04, 2024
Lead Product(s) : Simethicone
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable